Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Recommendations for treatment of individuals at risk for hereditary breast and ovarian carcinoma].

Srpski arhiv za celokupno lekarstvo - 1 Jan 2000

Radulović Sinisa, Branković-Magić Mirjana, Janković Radmila, Ristanović Momcilo

Abstract excerpt

Germline mutations in BRCA 1 and BRCA 2 gene have been recognized as hereditary predisposition for breast and ovarian cancer for many years. The optimal clinical management of individuals at risk for hereditary breast and ovarian cancer are not completely defined. Current surveillance options are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genetic Predisposition to Disease
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ovarian Neoplasms

Share to Risk Factors

Source

Identifiers

PMID: 14692152

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-14692152-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Recommendations for treatment of individuals at risk for hereditary breast and ovarian carcinoma].PMID 14692152Read ↗

Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer.Semantic proximity Read ↗

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.Semantic proximity Read ↗

[Clinical counseling and care of women with genetic predisposition to breast and ovarian carcinoma].Semantic proximity Read ↗

NSGC Practice Guideline: Risk Assessment and Genetic Counseling for Hereditary Breast and Ovarian CancerSemantic proximity Read ↗

[Inherited breast and ovarian cancers].Semantic proximity Read ↗

Hereditary breast-ovarian cancer: clinical findings and medical management.Semantic proximity Read ↗

Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening.Semantic proximity Read ↗

Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline.Semantic proximity Read ↗

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.Semantic proximity Read ↗

The counseling and management of young healthy BRCA mutation carriers.Semantic proximity Read ↗

[Gynecological Care and Prevention of Gynecological Malignancies in BRCA1 and BRCA2 Mutation Carriers].Semantic proximity Read ↗

An overview of hereditary breast and ovarian cancer syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.